Also found in: Thesaurus, Medical, Acronyms, Wikipedia.


An antiviral drug, C8H11N3O3S, that is a nucleoside reverse transcriptase inhibitor and is used in the treatment of chronic hepatitis B and, in combination with other drugs, in the treatment of HIV infection.

[Probably (methy)l + ami(no)- + -vudine, antiviral suff. (from zidovudine).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.lamivudine - a nucleoside reverse transcriptase inhibitor that is very effective in combination with zidovudine in treating AIDS and HIVlamivudine - a nucleoside reverse transcriptase inhibitor that is very effective in combination with zidovudine in treating AIDS and HIV
NRTI, nucleoside reverse transcriptase inhibitor - an antiviral drug used against HIV; is incorporated into the DNA of the virus and stops the building process; results in incomplete DNA that cannot create a new virus; often used in combination with other drugs
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.


n lamivudina
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
The TANGO study was conducted to assess whether adults living with HIV-1 who had maintained viral suppression for at least six months on a tenofovir alafenamide fumarate, or TAF,-containing regimen of at least three drugs, were able to maintain similar rates of viral suppression after switching to the 2-drug regimen, or 2DR, of dolutegravir plus lamivudine in a fixed dose combination, compared to continuing the TAF-containing regimen.
One generic HIV drug, lamivudine, stood out because of its activity and low side effects.
Lamivudine's efficacy and safety in preventing mother-to-child transmission of hepatitis B: A meta-analysis study
(8-10 ) For lamivudine, the prevalence of resistance rises rapidly, reaching 80% after five years of monotherapy (11) The pattern of rtL180M/M204V is the most common lamivudine-resistant HBV variant, with a prevalence of 60%.
Patients between 18 and 70 years receiving oral antiviral agents (lamivudine, entecavir, or tenofovir disproxil fumarate) for a minimum duration of 3 years due to CHB were included.
In 2010, the World Health Organization (WHO) recommended HBV screening before ART initiation, and the use of ART regimens containing tenofovir plus either lamivudine or emtricitabine for HIV/ HBV coinfection.
Two regimen were there based on Tenofovir:Tenofovir, Lamivudine and Nevirapine Regimen and Tenofovir, Lamivudine and Efavirenz Regimen.
Oral lamivudine (GlaxoSmithKline, Brentford, UK), a US Food and Drug Administration-approved anti-HIV drug, has been suggested as a possible antiviral agent against Ebola virus (EBOV).
Lamivudine (4 mg/kg/day) was given to 29 of the patients who were given treatment, interferon-[alpha] (IFN-[alpha]) (6 MU/[m.sup.2], three days a week) was given to 3 patients at the same dose and both IFN-[alpha] and lamivudine were given to 4 patients.
The lamivudine and telbivudine are prone to develop resistance rapidly.
Group A received a non-nucleoside reverse transcriptase inhibitor (NNRTI), lamivudine, and abacavir.